Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Status:
Completed
Trial end date:
2017-12-08
Target enrollment:
Participant gender:
Summary
This study is being done to evaluate the toxicity and safety of carboplatin administered by
convection enhanced delivery into the tumor in patients with high grade glial neoplasms. This
study is a dose escalating study, (the dose of the study drug is increased at set time
points). Carboplatin is in a class of drugs known as platinum-containing compounds; it slows
or stops the growth of cancer cells in your body. Convection enhanced delivery involves
placing one or more catheters into the brain and delivering chemotherapy through those
catheters directly into the brain